Related Experiment Video

Updated: Jan 23, 2026

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
04:25

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases

Published on: November 8, 2024

2.3K

Successful Treatment with Topical Diphenylcyclopropenone for Three Cases of Anogenital Warts in Children

Kazunori Miyata1, Usho Go1, Masaru Fujita1

  • 1Department of Dermatology, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan.

Case Reports in Dermatology
|June 12, 2019
PubMed

Insights

Topical diphenylcyclopropenone (DPCP) offers a less painful treatment for anogenital warts in children. This immunotherapy provides a viable alternative for pediatric patients resistant to conventional therapies.

Area of Science:

  • Pediatric Dermatology
  • Immunology
  • Dermatology

Background:

  • Anogenital warts, caused by human papillomavirus (HPV) types 6 and 11, are uncommon in children.
  • Conventional treatments for pediatric anogenital warts are often painful, necessitating anesthesia and posing challenges for young patients.

Observation:

  • This study reports on three pediatric cases of anogenital warts.
  • The patients presented with recalcitrant warts that were difficult to manage with standard therapies.

Findings:

  • Successful treatment of anogenital warts in children was achieved using topical diphenylcyclopropenone (DPCP).
  • DPCP, a contact immunotherapy, demonstrated efficacy in these pediatric cases.

Implications:

  • Topical DPCP may serve as a valuable, less invasive therapeutic option for pediatric anogenital warts.
  • This approach could benefit children who struggle with painful destructive treatments for HPV-related warts.

Keywords:
Anogenital wartsChildrenDiphenylcyclopropenoneHuman papillomavirus type 6

More Related Videos

Anogenital Distance and Perineal Measurements of the Pelvic Organ Prolapse POP Quantification System03:49

Anogenital Distance and Perineal Measurements of the Pelvic Organ Prolapse POP Quantification System

Published on: September 20, 2018

20.8K
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.8K

Related Concept Videos

Ecological Succession02:17

Ecological Succession

Ecological succession is influenced by the processes of facilitation, inhibition, and toleration. Facilitation occurs when early successional species create more favorable ecological conditions for subsequent species, such as enhanced nutrient, water, or light availability. In contrast, inhibition happens when early successional species create unfavorable ecological conditions for potential successive species, such as limiting resource availability. In some cases, later successional species...
21.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
265
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
845
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
969
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K